Pittsburgh (AP) -- a pharmacy that has had to turn away hepatitis C patients who couldn't pay $1,400 a month for the only treatment available has started selling the drugs itself at half the price.
The Food and Drug Administration on Wednesday approved a powerful combination of two antiviral drugs to treat chronic hepatitis C, a liver infection that can lead to cirrhosis, liver cancer and liver failure.
Four million Americans are estimated to have chronic hepatitis C, and 10,000 die from it each year.
Only 10 to 15 percent of patients remain in remission, six months after treatment is stopped.
The Food and drug Administration Wednesday approved the expanded use of Rebetron, a treatment already on the market for hepatitis C, a viral infection of the liver that can lead to cirrhosis, liver cancer and liver failure.
Boston -- it started with an earache.
Beijing, May 22 (Xinhua) -- China has started to put into mass production a genetic engineering drug which can effectively treat liver diseases.
New DELHI, December 15 (Xinhua) -- two new drugs that e Press Trust of India while attending a symposium on transfusion associated hepatitis here.
Interferon-based therapy, however, works only in one-third of the cases, while about 70 percent of the patients do not benefit from it.
Ottawa, November 20 (Xinhua) -- People infected with hepatitis C may have a better chance of a cure after researchers in Canada discovered a new combination of drugs to treat the disease.
